Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Nuclear & Safety and Medical. The Medical includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For Nuclear Power Plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 15.55% year-on-year.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 168.53, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 291.07M shares, increasing 3.94% quarter-over-quarter.
Held by Leon Cooperman
Star Investor Leon Cooperman holds 9.19M shares of this stock.